⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
globenewswire.com
ALGS
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
globenewswire.com
ALGS
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
globenewswire.com
ALGS
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
globenewswire.com
ALGS